Cargando…
Serological Biomarkers of Hepatocellular Carcinoma in Egyptian Patients
Hepatocellular carcinoma (HCC) is one of the most aggressive cancers worldwide. In Egypt, the disease is usually detected in an advanced stage at which no treatment may be effective including surgery. Early detection of the disease is thus an important goal allowing the patient to be treated before...
Autores principales: | El-Tayeh, Sarmad F., Hussein, Tarek D., El-Houseini, Motawa E., Amer, Mahmoud A., El-Sherbini, Mamdooh, Elshemey, Wael M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826907/ https://www.ncbi.nlm.nih.gov/pubmed/22430192 http://dx.doi.org/10.3233/DMA-2011-0883 |
Ejemplares similares
-
Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects
por: Afifi, Ahmed M, et al.
Publicado: (2019) -
Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma
por: Gabeen, Abdulwahab Ali, et al.
Publicado: (2014) -
Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients
por: Abdelaziz, Heba E., et al.
Publicado: (2022) -
The potential immuno-stimulating effect of curcumin, piperine, and taurine combination in hepatocellular carcinoma; a pilot study
por: kotb, Raghda R., et al.
Publicado: (2023) -
Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients
por: Motawi, Tarek K., et al.
Publicado: (2015)